Cargando…
Leukotriene A(4) Hydrolase Is a Candidate Predictive Biomarker for Successful Allergen Immunotherapy
BACKGROUND: Allergic rhinitis is a common disorder that affects 10% to 40% of the population worldwide. Allergen immunotherapy (AIT) represents the only therapy that has the potential to resolve clinical symptoms of allergic rhinitis. However, up to 30% of patients do not respond to AIT. Biomarkers...
Autores principales: | Ma, Ting-Ting, Cao, Meng-Da, Yu, Rui-Li, Shi, Hai-Yun, Yan, Wei-Jun, Liu, Jian-Guo, Pan, Chen, Sun, Jinlyu, Wei, Qing-Yu, Wang, De-Yun, Wei, Ji-Fu, Wang, Xue-Yan, Yin, Jin-Shu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732448/ https://www.ncbi.nlm.nih.gov/pubmed/33329520 http://dx.doi.org/10.3389/fimmu.2020.559746 |
Ejemplares similares
-
Predicting Success of Allergen-Specific Immunotherapy
por: Zissler, Ulrich M., et al.
Publicado: (2020) -
Formulations for Allergen Immunotherapy in Human and Veterinary Patients: New Candidates on the Horizon
por: Pali-Schöll, Isabella, et al.
Publicado: (2020) -
Mechanisms and biomarkers of successful allergen-specific immunotherapy
por: López, Juan-Felipe, et al.
Publicado: (2022) -
Characteristics of candidates for allergen immunotherapy
por: Ciprandi, Giorgio, et al.
Publicado: (2013) -
The Molecular Allergen Recognition Profile in China as Basis for Allergen-Specific Immunotherapy
por: D’souza, Nishelle, et al.
Publicado: (2021)